A Paradigm Shift In Container Closure Integrity Of Parenteral Drugs
Source: PTI Packaging and Inspection Systems
By Oliver Stauffer, CEO , PTI Inspection
![MicroCurrent HVLD MicroCurrent HVLD](https://vertassets.blob.core.windows.net/image/53d61e64/53d61e64-ac49-4721-b978-3951d4c05b61/375_250-manufacturing_liquid_filling_vials_450x300.jpg)
If there is a leak or breach of the sterile barrier, environmental contaminants can rapidly convert a life-saving treatment into a microbial soup. The latest evolution of HVLD, PTI’s patent pending MicroCurrent technology, aims to achieve a high level of CCI assurance across the entire range of parenteral products.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Med Device Online? Subscribe today.
Subscribe to Med Device Online
X
Subscribe to Med Device Online
PTI Packaging and Inspection Systems
This website uses cookies to ensure you get the best experience on our website. Learn more